125 related articles for article (PubMed ID: 9743227)
21. The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity.
Storey RF; Sanderson HM; White AE; May JA; Cameron KE; Heptinstall S
Br J Haematol; 2000 Sep; 110(4):925-34. PubMed ID: 11054084
[TBL] [Abstract][Full Text] [Related]
22. Activation of phospholipase C and protein kinase C has little involvement in ADP-induced primary aggregation of human platelets: effects of diacylglycerols, the diacylglycerols, the diacylglycerol kinase inhibitor R59022, staurosporine and okadaic acid.
Packham MA; Livne AA; Ruben DH; Rand ML
Biochem J; 1993 Mar; 290 ( Pt 3)(Pt 3):849-56. PubMed ID: 8384448
[TBL] [Abstract][Full Text] [Related]
23. Characterization of in vitro and in vivo platelet responses to thrombin and thrombin receptor-activating peptides in guinea pigs.
Chiu PJ; Tetzloff GG; Foster C; Chintala M; Sybertz EJ
Eur J Pharmacol; 1997 Feb; 321(1):129-35. PubMed ID: 9083795
[TBL] [Abstract][Full Text] [Related]
24. In vitro effects of aprosulate sodium, a novel anticoagulant, on platelet activation: possible mechanism for antiplatelet action.
Sugidachi A; Breiter N; Ogawa T; Asai F; Koike H
Thromb Haemost; 1996 Nov; 76(5):786-90. PubMed ID: 8950791
[TBL] [Abstract][Full Text] [Related]
25. Streptokinase-induced platelet activation involves antistreptokinase antibodies and cleavage of protease-activated receptor-1.
McRedmond JP; Harriott P; Walker B; Fitzgerald DJ
Blood; 2000 Feb; 95(4):1301-8. PubMed ID: 10666203
[TBL] [Abstract][Full Text] [Related]
26. The serine protease granzyme A does not induce platelet aggregation but inhibits responses triggered by thrombin.
Suidan HS; Clemetson KJ; Brown-Luedi M; Niclou SP; Clemetson JM; Tschopp J; Monard D
Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):939-45. PubMed ID: 8645180
[TBL] [Abstract][Full Text] [Related]
27. Rabbit and rat platelets do not respond to thrombin receptor peptides that activate human platelets.
Kinlough-Rathbone RL; Rand ML; Packham MA
Blood; 1993 Jul; 82(1):103-6. PubMed ID: 8391870
[TBL] [Abstract][Full Text] [Related]
28. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
Connolly TM; Limbird LE
Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
[TBL] [Abstract][Full Text] [Related]
29. A critical role of thrombin/PAR-1 in ADP-induced platelet secretion and the second wave of aggregation.
Jiang L; Xu C; Yu S; Liu P; Luo D; Zhou Q; Gao C; Hu H
J Thromb Haemost; 2013 May; 11(5):930-40. PubMed ID: 23406164
[TBL] [Abstract][Full Text] [Related]
30. Protein kinase C- and calcium-regulated pathways independently synergize with Gi pathways in agonist-induced fibrinogen receptor activation.
Quinton TM; Kim S; Dangelmaier C; Dorsam RT; Jin J; Daniel JL; Kunapuli SP
Biochem J; 2002 Dec; 368(Pt 2):535-43. PubMed ID: 12215172
[TBL] [Abstract][Full Text] [Related]
31. Effects of a polyoxyethylene detergent (Brij 58) on platelet aggregation, release and clotting activity.
Barton PG
Biochim Biophys Acta; 1978 Feb; 539(1):98-113. PubMed ID: 623796
[TBL] [Abstract][Full Text] [Related]
32. Apolipoprotein (a) mediates the lipoprotein (a)-induced biphasic shift in human platelet cyclic AMP.
Barre DE
Thromb Res; 2003; 112(5-6):321-4. PubMed ID: 15041277
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the distinct mechanism of agonist-induced canine platelet activation.
Chaudhary PK; Kim S
J Vet Sci; 2019 Jan; 20(1):10-15. PubMed ID: 30541187
[TBL] [Abstract][Full Text] [Related]
34. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
Krishnamurthi S; Westwick J; Kakkar VV
Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
[TBL] [Abstract][Full Text] [Related]
35. YD-3, a novel inhibitor of protease-induced platelet activation.
Wu CC; Huang SW; Hwang TL; Kuo SC; Lee FY; Teng CM
Br J Pharmacol; 2000 Jul; 130(6):1289-96. PubMed ID: 10903968
[TBL] [Abstract][Full Text] [Related]
36. A trypsin-like platelet protease propagates protease-activated receptor-1 cleavage and platelet activation.
Ofosu FA; Freedman J; Dewar L; Song Y; Fenton JW
Biochem J; 1998 Dec; 336 ( Pt 2)(Pt 2):283-5. PubMed ID: 9820801
[TBL] [Abstract][Full Text] [Related]
37. PAR-4 agonist AYPGKF stimulates thromboxane production by human platelets.
Henriksen RA; Hanks VK
Arterioscler Thromb Vasc Biol; 2002 May; 22(5):861-6. PubMed ID: 12006403
[TBL] [Abstract][Full Text] [Related]
38. Effect of physiologic shear stresses and calcium on agonist-induced platelet aggregation, secretion, and thromboxane A2 formation.
Viisoreanu D; Gear A
Thromb Res; 2007; 120(6):885-92. PubMed ID: 17306868
[TBL] [Abstract][Full Text] [Related]
39. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease.
Furman MI; Benoit SE; Barnard MR; Valeri CR; Borbone ML; Becker RC; Hechtman HB; Michelson AD
J Am Coll Cardiol; 1998 Feb; 31(2):352-8. PubMed ID: 9462579
[TBL] [Abstract][Full Text] [Related]
40. Thrombopoietin primes human platelet aggregation induced by shear stress and by multiple agonists.
Oda A; Miyakawa Y; Druker BJ; Ozaki K; Yabusaki K; Shirasawa Y; Handa M; Kato T; Miyazaki H; Shimosaka A; Ikeda Y
Blood; 1996 Jun; 87(11):4664-70. PubMed ID: 8639835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
